Skip to main content

Advertisement

Table 1 Eight Caucasian male subjects were enrolled into the study. All subjects had four PET/CT scans, except subject 122 who declined further participation after the first two scanning sessions for availability reasons

From: The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans

Subject Age (years) Weight (kg) BMI (kg/m2) Dose of radioactivity (MBq)
105 54 76.1 25.7 12.77
110 53 72.2 22.8 14.53
122 54 68.6 23.5 14.24
123 60 92.3 27.6 13.27
125 53 91.8 27.4 14.64
127 56 70.2 21.4 14.72
132 54 73.0 20.9 15.03
135 56 83.1 23.3 13.06